Skip to content
PICO Portalanswers from OpenAlex

Thromboembolic disease associated with ovarian stimulation and assisted conception techniques

PaperCitations, authors & open-access status

Thromboembolic disease associated with ovarian stimulation and assisted conception techniques is a paper indexed in PICO Portal from OpenAlex.

How many citations does Thromboembolic disease associated with ovarian stimulation and assisted conception techniques have?

PICO Portalcitation count

Thromboembolic disease associated with ovarian stimulation and assisted conception techniques has 157 citations in the OpenAlex counts PICO Portal stores.

When was Thromboembolic disease associated with ovarian stimulation and assisted conception techniques published?

PICO Portalyear

Thromboembolic disease associated with ovarian stimulation and assisted conception techniques has 1997 year in the PICO Portal index.

What is the open-access status of Thromboembolic disease associated with ovarian stimulation and assisted conception techniques?

PICO Portaloa status

Thromboembolic disease associated with ovarian stimulation and assisted conception techniques has bronze oa status in the PICO Portal index.

What is the DOI of Thromboembolic disease associated with ovarian stimulation and assisted conception techniques?

PICO Portaldoi

The DOI for Thromboembolic disease associated with ovarian stimulation and assisted conception techniques is on the source record.

What is the PMID of Thromboembolic disease associated with ovarian stimulation and assisted conception techniques?

PICO Portalpmid

The PMID for Thromboembolic disease associated with ovarian stimulation and assisted conception techniques is on the source record.

What is the OpenAlex record for Thromboembolic disease associated with ovarian stimulation and assisted conception techniques?

PICO Portalopenalex

The OpenAlex for Thromboembolic disease associated with ovarian stimulation and assisted conception techniques is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial